Exclusive

Publication

Byline

Singapore pilots personalised transcranial magnetic stimulation for treatment resistant depression

Singapore, April 13 -- The Institute of Mental Health (IMH), in collaboration with the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine), has embarked on two clini... Read More


Serum Institute of India partners with Univercells to make personalised cancer treatments more accessible

Singapore, April 12 -- Serum Institute of India (SII), the world's largest vaccine manufacturer, has joined forces with Univercells, a Belgian biotech innovator, targeting a dramatic increase in acces... Read More


World Orphan Drug Alliance expands to Japan & South Korea

Singapore, April 12 -- The World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in comp... Read More


BIO Asia-Taiwan 2024 opens July 24th

Singapore, April 11 -- Global biotech opportunities viewed with an Asian touch Conference Expands into Three Tracks: Innovation & Technology, Investment, and Regional Cooperation Participation from 50... Read More


Boehringer Ingelheim takes cancer therapies to China in partnership with Sino Biopharma

Singpore, April 10 -- Sino Biopharmaceutical Group has entered into a strategic partnership with Germany-headquartered Boehringer Ingelheim to bring Boehringer Ingelheim's innovative cancer therapies ... Read More


Ascend Advanced Therapies Acquires CMC Team and Facility in Florida from Beacon Therapeutics

Singapore, April 9 -- Strategic Move Expands Ascend's Gene Therapy Capabilities and Secures Long-Term Supply Partnership for Beacon Therapeutics' Sight Saving Therapies. Ascend Advanced Therapies (A... Read More


French sales subsidiary of Japanese pharma firm Eisai divests rights of neurology drugs for

Singapore, April 9 -- Japan headquartered pharma company Eisai Co. has announced that its French sales subsidiary Eisai S.A.S. has entered into an agreement to transfer the rights in France, the Frenc... Read More


MAIWEIJIAN becomes first approved biosimilar of Denosumab (120mg) in China

Singapore, April 9 -- Biopharmaceutical company Mabwell has announced that Denosumab Injection (trade name- MAIWEIJIAN) developed by its wholly-owned subsidiary T-mab has officially obtained the marke... Read More


Merck expands M Lab collaboration center in Shanghai with additional Euro 14 M investment

Singapore, April 8 -- Merck, a leading science and technology company, has expanded its M Lab Collaboration Center in Shanghai, the company's largest in its global network of ten interconnected labs. ... Read More


New research partnership with UK to improve health in China's Greater Bay area

Singapore, April 8 -- Researchers at the University of Birmingham, UK and Seventh Affiliated Hospital of Sun Yat-sen University, China have joined forces to launch a joint clinical research institute ... Read More